BRCA1/2- mutationcarriers

SND-ID: EXT 0104

This study is part of the collection Scania Metadatabase for Epidemiology (SME)

Creator/Principal investigator(s)

Håkan Olsson - Lund University, Faculty of Medicine, The Division of Oncology and Pathology

Description

The cohort, which is part of an international collaboration with IBCCS and Cimba, is covering all (both men and women) who have undergone mutation testing for BRCA1 or 2 in the Southern health region since 1993. It is the largest registry of hereditary cancer in Sweden with 1200 cases. Most individuals have filled in a questionnaire concerning diet, body weight and body measurements, family history, BRCA1/2 status, reproduction and use of oral contraceptives. Blood samples are collected from all participants.

Purpose:

To study risk factors studies in hereditary breast cancer

Research principal, contributors, and funding

Research principal

Lund University

Responsible department/unit

Lund University, Faculty of Medicine

Protection and ethical review

Method

Unit of analysis

Individual

Population

The population includes all men and women, tested for mutation BRCA1 or 2 in the southern health region since 1993.

Time Method

Cross-section

Sampling procedure

Probability: Systematic random

Time period(s) investigated

1993–ongoing

Geographic coverage

Topic and keywords

Subject area

HEALTH (CESSDA Topic Classification)
Medical Genetics, Cancer and Oncology (The Swedish standard of fields of research 2011)

Keywords

contraceptive devices, body weights and measures, neoplasms, medical history taking, breast neoplasms, reproduction, heredity, scania, epihealth_skåne, brca1, blood sample, genetic studies, epihealth, brca2

Publications

Sort by name | Sort by year

Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 2008 Apr;82(4):937-48. doi: 10.1016/j.ajhg.2008.02.008.
Read full text

Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, et al. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Br J Cancer. 2009 Dec 15;101(12):2048-54. doi: 10.1038/sj.bjc.6605416.
Read full text

If you have published anything based on these data, please notify us with a reference to your publication(s). If you are responsible for the catalogue entry, you can update the metadata/data description in DORIS.

Access to data via

Homepage

IBCCS

CIMBA

Contact

Håkan Olsson

Information about using data

Dataset

BRCA1- or BRCA2-mutationscarriers

Description

The dataset includes all men and women, tested for mutations in BRCA1 or BRCA2, in the southern health region since 1993.

Data format / data structure